NLRP3 and Parkinson disease: Pathogenic protein aggregates, such as α-synuclein, initiate NLRP3 activation in the microglial cells, activating ASC, caspase-1, and the secretion of proinflammatory cytokines IL-1β and IL-18, and then contribute to the disease progression of Parkinson’s disease [42].